SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032270
Filing Date
2021-06-09
Accepted
2021-06-09 16:22:45
Documents
12
Period of Report
2021-06-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K - ANNUAL MEETING RESULTS kdny-8k_20210604.htm   iXBRL 8-K 53446
  Complete submission text file 0001564590-21-032270.txt   184951

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kdny-20210604.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20210604_lab.xml EX-101.LAB 19469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20210604_pre.xml EX-101.PRE 11633
5 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20210604_htm.xml XML 3567
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 211005359
SIC: 2834 Pharmaceutical Preparations